View of STUDY ON CLINICAL AND PARACLINICAL CHARACTERISTICS AND RESULTS OF TREATMENT WITH DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION IN CAN THO CARDIOVASCULAR HOSPITAL IN 2023 - 2025

Return to Article Details STUDY ON CLINICAL AND PARACLINICAL CHARACTERISTICS AND RESULTS OF TREATMENT WITH DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION IN CAN THO CARDIOVASCULAR HOSPITAL IN 2023 - 2025 Download Download PDF